| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 632,500 | 13 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Chief Financial Officer | 15 Jun 2023, 18:09 |
| TCRX | TScan Therapeutics, Inc. | 27 Dec 2022 | 2 | +$9,217 | 4 | Chief Financial Officer | 29 Dec 2022, 13:34 |
| TCRX | TScan Therapeutics, Inc. | 25 Jul 2022 | 1 | $0 | 4 | Chief Financial Officer | 27 Jul 2022, 16:30 |
| TCRX | TScan Therapeutics, Inc. | 24 Mar 2022 | 1 | +$50,982 | 4 | Chief Financial Officer | 28 Mar 2022, 16:31 |
| TCRX | TScan Therapeutics, Inc. | 18 Jan 2022 | 1 | $0 | 4 | Chief Financial Officer | 20 Jan 2022, 15:26 |
| TCRX | TScan Therapeutics, Inc. | 21 Sep 2021 | 1 | +$31,585 | 4 | Chief Financial Officer | 22 Sep 2021, 18:51 |
| TCRX | TScan Therapeutics, Inc. | 09 Sep 2021 | 1 | +$49,925 | 4 | Chief Financial Officer | 13 Sep 2021, 16:37 |
| TCRX | TScan Therapeutics, Inc. | 15 Jul 2021 | 1 | +$15,000 | 4 | Chief Financial Officer | 22 Jul 2021, 07:37 |
| TCRX | TScan Therapeutics, Inc. | 15 Jul 2021 | 1 | $0 | 4 | Chief Financial Officer | 16 Jul 2021, 16:40 |
| TCRX | TScan Therapeutics, Inc. | 15 Jul 2021 | 0 | $0 | 3 | Chief Financial Officer | 15 Jul 2021, 18:17 |